CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MetaboliQs aims to enhance cardiovascular diagnostics by integrating diamond-based quantum sensing with magnetic resonance imaging. This technology will allow for precise measurement of metabolic activity, leading to better personalized treatment options for cardiovascular diseases.
Cardiovascular Diseases (CVDs) are the number 1 cause of death globally: more people die annually from CVDs than from any other cause.
Despite emerging diagnostics tools and therapeutics, several areas of significant unmet need remain unaddressed among CVD patients.
The ability to personalize cardiovascular medical care and improve outcomes, will require characterization of disease processes at a molecular level.
The current state-of-the-art, e.g., Positron emission tomography (PET), does not pr…
FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, ULM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Muenchen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Zuerich
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Ettlingen
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
